ctDNA Assessment of EGFR Mutation Status in Chinese Patients with Advanced Non-Small-Cell Lung Cancer in Read World Setting

被引：1
|
作者：
Zhang, S. [1 ]
Zhu, L. [1 ]
Chen, X. [1 ]
Chen, E. [2 ]
Li, Y. [3 ]
Fang, H. [4 ]
Feng, Y. [5 ]
Qiong, Z. [6 ]
He, H. [7 ]
Ma, S. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Resp, Hangzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp, Wenzhou, Peoples R China
[4] Zhejiang Xiaoshan Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[5] Hangzhou Normal Univ, Affiliated Hosp, Dept Resp, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[7] Quzhou Peoples Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
ctDNA; ARMS; EGFR;
D O I：
10.1016/j.jtho.2017.09.1472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-031
引用
收藏
页码：S2212 / S2212
页数：1
相关论文
共 50 条
  • [21] Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
    Carlos Caicedo
    Maria Jose Garcia-Velloso
    Maria Dolores Lozano
    Tania Labiano
    Carmen Vigil Diaz
    Jose Maria Lopez-Picazo
    Alfonso Gurpide
    Javier Zulueta
    Jose Angel Richter Echevarria
    Jose Luis Perez Gracia
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 2058 - 2065
  • [22] Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
    Caicedo, Carlos
    Jose Garcia-Velloso, Maria
    Dolores Lozano, Maria
    Labiano, Tania
    Vigil-Diaz, Carmen
    Maria Lopez-Picazo, Jose
    Gurpide, Alfonso
    Zulueta, Javier J.
    Angel Richter-Echevarria, Jose
    Luis Perez-Gracia, Jose
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (11) : 2164 - 2164
  • [23] Real-world analysis of the prognostic value of EGFR mutation detection in plasma ctDNA from patients with advanced non-small cell lung cancer
    Long, Chaolian
    Li, Kun
    Liu, Zichen
    Zhang, Nana
    Xing, Xuya
    Xu, Liming
    Gai, Fei
    Che, Nanying
    [J]. CANCER MEDICINE, 2023, 12 (07): : 7982 - 7991
  • [24] EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer
    Nan, Xueli
    Xie, Chao
    Yu, Xueyan
    Liu, Jie
    [J]. ONCOTARGET, 2017, 8 (43) : 75712 - 75726
  • [25] Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer
    Kim, Jung Soo
    Cho, Min Seong
    Nam, Jong Hyeon
    Kim, Hyun-Jung
    Choi, Kyeng-Won
    Ryu, Jeong-Seon
    [J]. PLOS ONE, 2017, 12 (05):
  • [26] PROGNOSTIC IMPACT OF EGFR MUTATION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH FAMILY HISTORY OF LUNG CANCER
    Kwak, S. M.
    Soo, K. Jung
    Ryu, J. S.
    [J]. RESPIROLOGY, 2016, 21 : 111 - 111
  • [27] IMMUNOHISTOCHEMISTRY WITH MUTATION SPECIFIC ANTIBODIES DETECTING THE STATUS OF EGFR MUTATIONS IN NON-SMALL-CELL LUNG CANCER
    Yu, J.
    Li, D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S41 - S42
  • [28] Immunohistochemistry with Mutation Specific Antibodies Detecting the Status of EGFR Mutations in Non-Small-Cell Lung Cancer
    Li, D.
    Chen, S.
    Hu, C.
    Lei, Y.
    Yu, J.
    [J]. MODERN PATHOLOGY, 2010, 23 : 407A - 407A
  • [29] Immunohistochemistry with Mutation Specific Antibodies Detecting the Status of EGFR Mutations in Non-Small-Cell Lung Cancer
    Li, D.
    Chen, S.
    Hu, C.
    Lei, Y.
    Yu, J.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 407A - 407A
  • [30] EGFR mutation and response to chemotherapy in non-small-cell lung cancer (NSCLC) patients.
    Lee, KH
    Han, SW
    Jeong, S
    Kim, DW
    Chung, DH
    Im, SA
    Kim, TY
    Heo, DS
    Bang, YJ
    Kim, NK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
12345